| BIOVENTUS INC. A DL -001 |
| USA |
| US09075A1088 / A2APNA |
| 4B8 (Frankfurt) / BVS (NASDAQ) |
| FRA:4B8, ETR:4B8, 4B8:GR, NASDAQ:BVS |
| - |
| - |
|
Bioventus Inc. Class A Common Stock represents Bioventus Inc., a medical technology company focused on developing and commercializing products for musculoskeletal care and active healing. Bioventus serves patients and healthcare providers with orthob..
>Volltext.. |
| 1004.02 Mio. EUR |
| 1252.51 Mio. EUR |
| 521.35 Mio. EUR |
| 95.6 Mio. EUR |
| 48.8 Mio. EUR |
| 0.72 EUR |
| 236.33 Mio. EUR |
| 26.39 Mio. EUR |
| 86.18 Mio. EUR |
| 0.19 |
| 6.38% |
| - |
| - |
| - |
| - |
| - |
| 03.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|